Log in to comment on videos and join in on the fun.
Watch the live stream of ӣƵ and full episodes.
Reduce eye strain and focus on the content that matters.
Board certified rheumatologist Dr. Mahsa Tehrani discusses Novo Nordisk's decision to dramatically cut the U.S. list prices for its popular diabetes and weight-loss drugs Ozempic and Wegovy on ‘America Reports.’